Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study (Q45892863)
Jump to navigation
Jump to search
scientific article published on 4 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study |
scientific article published on 4 November 2015 |
Statements
1 reference
Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study (English)
1 reference
1 reference
Alexander Stein
1 reference
Kerstin Kapp
1 reference
Werner Scheithauer
1 reference
Ramon Salazar
1 reference
Michel Ducreux
1 reference
Tom Waddell
1 reference
Dirk Arnold
1 reference
Christophe Tournigand
1 reference
Alberto Sobrero
1 reference
Eric Van Cutsem
1 reference
Manuel Schmidt
1 reference
4 November 2015
1 reference
1 reference
3
1 reference
P173-P173
1 reference
Suppl 2
1 reference
Identifiers
1 reference
1 reference